Last quarter (Q4 2023), Novo Nordisk's total revenue was $65.86B, an increase of 59.61% from the same quarter last year. In Q4, Novo Nordisk's net income was $21.96B. See Novo Nordisk’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 212.89B	$ 232.26B	$ 176.95B	$ ―	$ 126.95B	$ 122.02B
Cost of Revenue	$ 33.66B	$ 35.77B	$ 28.45B	$ ―	$ 20.93B	$ 20.09B
Gross Profit	$ 179.23B	$ 196.50B	$ 148.51B	$ ―	$ 106.01B	$ 101.93B
Operating Expense	$ 90.72B	$ 94.04B	$ 74.73B	$ ―	$ 51.89B	$ 50.05B
Operating Income	$ 88.52B	$ 102.45B	$ 73.78B	$ ―	$ 54.13B	$ 51.88B
Net Non Operating Interest Income Expense	$ -2.68B	$ 1.75B	$ -3.22B	$ ―	$ -2.29B	$ -3.93B
Other Income Expense	$ -566.00M	$ -156.00M	$ -910.00M	$ ―	$ ―	$ ―
Pretax Income	$ 86.70B	$ 104.67B	$ 68.58B	$ ―	$ 52.98B	$ 48.55B
Tax Provision	$ 16.93B	$ 20.99B	$ 13.54B	$ ―	$ 10.99B	$ 9.60B
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ 69.77B	$ 83.68B	$ 55.05B	$ ―	$ 41.99B	$ 38.95B
Basic EPS	$ 22.10	$ 18.67	$ 12.26	$ 20.79	$ 18.05	$ 16.41
Diluted EPS	$ 22.02	$ 18.62	$ 12.22	$ 20.74	$ 18.01	$ 16.38
Basic Average Shares	$ 15.78B	$ 4.48B	$ 4.53B	$ 2.30K	$ 2.33K	$ ―
Diluted Average Shares	$ 15.82B	$ 4.49B	$ 4.54B	$ 2.30K	$ 2.34K	$ ―
Dividend Per Share	$ 8.15	$ ―	$ 12.40	$ 10.40	$ 9.10	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 124.37B	$ 129.81B	$ 103.18B	$ ―	$ ―	$ ―
Net Income From Continuing And Discontinued Operation	$ 69.77B	$ 83.68B	$ 55.05B	$ ―	$ 41.99B	$ 38.95B
Normalized Income	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBITDA	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―

Currency in USD

Novo Nordisk Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing